# Neurelis: Pharmaceuticals, San Diego, United States

> Neurelis: Neurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.

Source: https://millionrounds.com/startup/neurelis (Millionrounds; every figure on the page links to its filing or article)

United States · [Pharmaceuticals startup](https://millionrounds.com/companies)

# Neurelis

Neurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.

Funding reported Last round: Series D

Pharmaceuticals San Diego, United States

Company summary

- **Founded:** 2007 19 years old
- **Team:** 101 51 to 200 people
- **Funding reported:** $206M in dollars
- **Last round:** Series D Mar 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Neurelis has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Neurelis raised

Funding, as reported

Reported in all **$206M** in dollars

Rounds **9**

Last round **Series D**

Last round date **Mar 2021**

Investors listed **5**

## Founders and team

From Neurelis's own website and the SEC filings it signed: 1 founder, 3 on the team.

**Craig C. Chambliss** President and CEO/Co-Founder *Named on its 2021 Form D*

- **Chuck DeWildt** Chief Commercial Officer
- **Jenny Alonso** General Counsel and Chief Compliance Officer
- **George F. Stuart** Executive Officer i

On the board, as filed i *David F. Hale* *Huaizheng C. Peng* *Kevin C. Li* *Priyanka F. Belawat* *Stephen F. Cartt*

## On 2 portfolio pages

Investors who name them

- [LYZZ Capital](https://millionrounds.com/fund/lyzz-capital)
- [OrbiMed](https://millionrounds.com/fund/orbimed)

Each firm lists Neurelis on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## How it ended, so far

Exit

Exit Buyer Price When

Acquired Biotie Therapies undisclosed Jun 2013

## Pharmaceuticals in United States

Startups like it

- [**AMAG Pharmaceuticals** Waltham · founded 1981](https://millionrounds.com/startup/amag-pharmaceuticals)
- [**PL Developments** Westbury · founded 1988](https://millionrounds.com/startup/pl-developments)
- [**Remedi SeniorCare** Baltimore · founded 1954](https://millionrounds.com/startup/remedi-seniorcare)
- [**Spectrum Pharmaceuticals** Lake Forest · founded 1987](https://millionrounds.com/startup/spectrum-pharmaceuticals)
- [**moksha8 Pharmaceuticals** Berwyn · founded 2007](https://millionrounds.com/startup/moksha8-pharmaceuticals)
- [**Amplyx Pharmaceuticals** San Diego · founded 2006](https://millionrounds.com/startup/amplyx-pharmaceuticals)
- [**Zosano Pharma** Fremont · founded 2006](https://millionrounds.com/startup/zosano-pharma)
- [**Alexza Pharmaceuticals** Fremont · founded 2001](https://millionrounds.com/startup/alexza-pharmaceuticals)

## Is this your company?

Add your raise, your deck and your story, and put Neurelis in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)